$19.30 0.01 (+0.08%)
11/6/2009 2:37 PM

Grupo Casa Saba, S.A. (ADR) (SAB)

CAPS Rating: 5 out of 5

The Company, through its subsidiaries, distributes pharmaceutical products, as well as health-and-beauty/other products, entertainment products, food/non-perishable products and office/electronic products.

Current Price $19.30 Mkt Cap $512.26M
Open $19.33 P/E Ratio 12.05
Prev. Close $19.28 Div. (Yield) 0.46 (2.40%)
Daily Range $19.25 - $19.33 Volume 7,500
52-Wk Range $11.14 - $23.25 Avg. Daily Vol. 3,000

SAB News and Commentary

Caps

How do you think SAB will perform vs the S&P 500?

Add Stock to Watchlist

All Members

144 Outperform
7 Underperform
 

All-Star Members

45 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top SAB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cdubbies (54.54)
Submitted June 16, 2009

This company is trading below tangible assets and has a strong financial position with little debt. Generic pharma should be a strong industry in tough economic times and this company has little competition in an emerging market, causing it's… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

SAB VS S&P 500 (SPY)

Fools bullish on SAB are also bullish on:

Fools bearish on SAB are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about SAB.

Recs

0
Member Avatar mrindependent (98.79) Submitted: 9/16/2009 11:58:34 AM : Outperform Start Price: $18.90 SAB Score: +1.68

Grupo Casa Saba, S.A.B. de C.V. (Grupo Casa Saba) is a multi-channel, multi-product national wholesale distributor in Mexico. The Company distributes pharmaceutical products, health, beauty aids and consumer goods, general merchandise, publications and other products. This largecap company consistently increases revenues and maintains high returns on equity (over 16%). Currently selling for just over book value, this company appears to be undervalued.

Report this Post 0 Comments | Reply | Permalink

Recs

3
Member Avatar cdubbies (54.54) Submitted: 6/16/2009 12:11:23 PM : Outperform Start Price: $17.49 SAB Score: -7.38

This company is trading below tangible assets and has a strong financial position with little debt. Generic pharma should be a strong industry in tough economic times and this company has little competition in an emerging market, causing it's profitability to be double the industry standard. This stock is probably undervalued because it lacks coverage from Wall St.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Seeley2620 (61.08) Submitted: 6/5/2009 12:55:12 PM : Outperform Start Price: $15.69 SAB Score: +6.46

P.A.Y.D.

Report this Post 0 Comments | Reply | Permalink
View All 17 Pitches »

Leaderboard

Find the members with the highest scoring picks in SAB.

Score Leader

LeanieBean

LeanieBean (32.81) Score: +63.42

The Score Leader is the member with the highest score across all their picks in SAB.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
kkotwani 99.66 4/14/2009 Outperform 5Y $12.63 +52.79% +28.31% +24.48
daverx3141 74.27 8/6/2007 Underperform 3M $34.79 -44.53% -21.80% +22.73
Adoboinside 53.44 8/1/2007 Underperform 3W $34.84 -44.61% -22.79% +21.81
jaguar88 63.71 12/11/2007 Underperform NS $37.08 -47.96% -26.23% +21.73
Mcserastral 69.22 4/7/2009 Outperform NS $12.63 +52.79% +31.75% +21.05
spacemonkeyy < 20 8/4/2009 Outperform 5Y $15.10 +27.81% +8.94% +18.87
buphetta 96.21 5/11/2009 Outperform NS $14.14 +36.52% +18.04% +18.47
SmallCapsInvstr 85.30 5/11/2009 Outperform 5Y $14.14 +36.52% +18.04% +18.47
steelheart100 < 20 7/28/2009 Outperform 5Y $15.25 +26.56% +10.21% +16.34
rmister 44.93 8/4/2009 Outperform NS $15.61 +23.64% +7.65% +15.98
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SAB.

Featured Broker Partners